| __timestamp | Jazz Pharmaceuticals plc | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 117418000 | 176081000 |
| Thursday, January 1, 2015 | 102526000 | 157939000 |
| Friday, January 1, 2016 | 105386000 | 164073000 |
| Sunday, January 1, 2017 | 110188000 | 169243000 |
| Monday, January 1, 2018 | 121544000 | 168489000 |
| Tuesday, January 1, 2019 | 127930000 | 172526000 |
| Wednesday, January 1, 2020 | 148917000 | 200649000 |
| Friday, January 1, 2021 | 440760000 | 237513000 |
| Saturday, January 1, 2022 | 540517000 | 353358000 |
| Sunday, January 1, 2023 | 435577000 | 586886000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. Jazz Pharmaceuticals plc and Lantheus Holdings, Inc. have shown intriguing trends in their cost of revenue from 2014 to 2023. Jazz Pharmaceuticals saw a significant rise, peaking in 2022 with a 360% increase from 2014. Meanwhile, Lantheus Holdings experienced a steady climb, culminating in a 233% increase by 2023. This growth reflects strategic investments and market expansion efforts. Notably, Jazz's costs surged in 2021, aligning with industry-wide shifts. Lantheus, on the other hand, maintained a more consistent growth trajectory, highlighting its stable operational model. These insights offer a window into the financial strategies of two key players in the pharmaceutical sector, emphasizing the importance of cost management in sustaining competitive advantage.
Novo Nordisk A/S vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down AbbVie Inc. and Jazz Pharmaceuticals plc's Expenses
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Vericel Corporation
Cost of Revenue Trends: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Galapagos NV
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs MorphoSys AG
Analyzing Cost of Revenue: Lantheus Holdings, Inc. and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Lantheus Holdings, Inc. vs Taro Pharmaceutical Industries Ltd.
Lantheus Holdings, Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored